Aspirin and Rosuvastatin Explained: Rosomni-A 75/10

Aspirin, chemically acetylsalicylic acid, grew out of salicylates found in willow bark and has been in medical use for well over a century. For most of that time it was known as a painkiller and fever medicine.

Its cardiac role came later, once researchers understood that aspirin blocks the enzyme cyclo-oxygenase permanently rather than temporarily. Platelets have no nucleus, so they cannot make fresh enzyme. One small daily dose keeps their thromboxane A2 production suppressed for the whole life of that platelet, roughly a week to ten days.

This is why the antiplatelet dose is small. At 75 mg the drug is aiming at platelets, not at inflammation. Higher doses do not add antiplatelet benefit but do add stomach and bleeding risk, which is one reason self-adjusting the dose is a bad idea.

Rosuvastatin belongs to the statin family, formally the HMG-CoA reductase inhibitors. All statins interrupt the same early step in the liver's cholesterol assembly line, but they differ in potency, in how long they last and in how they are handled by the body.

Rosuvastatin is among the more potent members of the class, so a modest milligram number can achieve a substantial fall in LDL cholesterol. It is hydrophilic, meaning water-loving rather than fat-loving, and it is taken up quite selectively by liver cells. It has a long duration of action, which is why it does not need to be taken at bedtime the way short-acting statins traditionally were. It is also metabolised only to a small extent by the liver's CYP3A4 pathway, so it escapes several interactions that trouble some other statins.

Doctors also know that blood levels of rosuvastatin tend to run higher in people of Asian ancestry, which is one reason prescribers in India are careful about the milligram strength they choose.

Atherosclerosis has two faces. There is the slow build-up of cholesterol-rich plaque in the artery wall, and there is the sudden clot that forms when a plaque cracks. A statin addresses the first. An antiplatelet addresses the second. Neither substitutes for the other, which is why cardiologists so often prescribe them together.

A fixed-dose combination brings the two into one capsule for the patient whose doctor wants exactly that pairing. The point is adherence. Cardiac patients frequently take four, five or more medicines, and every extra strip is an extra chance to forget. Combining does not make either ingredient stronger and it does not remove either ingredient's cautions.

The trade-off is flexibility. If a doctor later wants a different statin strength or wants to pause the aspirin, a fixed combination cannot be split. That decision has to be made by the prescriber, who will simply change the prescription.

The generic name of the product tells you how it is built: Aspirin Gastro-resistant and Rosuvastatin Capsules IP. Inside the hard gelatin shell are two populations of pellet.

The aspirin pellets carry a gastro-resistant, sometimes called enteric, coating. It is formulated to resist stomach acid and to break down in the less acidic environment further along the gut. The intention is to spare the stomach lining from direct contact. It reduces local irritation, though it cannot remove the bleeding risk that comes from aspirin's effect on platelets throughout the body.

The rosuvastatin pellets release in the usual way, since there is no reason to delay them.

The letters IP stand for Indian Pharmacopoeia, the official standard book of medicine quality in India. When a label says Aspirin IP 75 mg and Rosuvastatin Calcium IP, it is declaring that the ingredients meet those published standards for identity, purity and content.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.